Besides HL, mutations negatively affecting the function of IκBα have been reported, albeit at lower frequency, in MALT lymphoma and in DLBCL, similarly providing an alternative mechanism for NF-κB activation in these tumor entities [202,203,204]. Here, NFKB1 is linked to Hodgkins lymphoma.